Comments
Loading...
Opus Genetics (IRD) Forecast
NewsEarningsOpus Genetics (IRD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOpus Genetics (NASDAQ:IRD) Stock Quotes, Forecast and News Summary
Opus Genetics Stock (NASDAQ: IRD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Opus Genetics (IRD) stock?
You can purchase shares of Opus Genetics (NASDAQ:IRD) through any online brokerage.
Who are Opus Genetics (IRD) competitors?
Other companies in Opus Genetics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Rani Therapeutics Hldgs (NASDAQ:RANI).
What is the forecast, or price target, for Opus Genetics (IRD) stock?
Opus Genetics has a consensus price target of $8.00.
What is the current price for Opus Genetics (IRD)?
The stock price for Opus Genetics (NASDAQ: IRD) is $1.17 last updated January 15, 2025 at 1:36 PM EST.
Does Opus Genetics (IRD) pay a dividend?
There are no upcoming dividends for Opus Genetics.
When is Opus Genetics (NASDAQ:IRD) reporting earnings?
Opus Genetics’s Q4 earnings are confirmed for Saturday, February 15, 2025.
Is Opus Genetics (IRD) going to split?
There is no upcoming split for Opus Genetics.
What sector and industry does Opus Genetics (IRD) operate in?
Opus Genetics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.